William A. Zammarrelli - Department of Surgery, Memorial Sloan Kettering Cancer Center

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 21 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Sensitivity of HER2-low Uterine Carcinosarcoma Organoids to the Antibody-Drug Conjugate, Trastuzumab Deruxtecan

Sara Moufarrij,Higinio Dopeso,Hunter Green, Kaitlyn Gill,David Brown,William Zammarrelli, Nancy Varice,Michelle Wu,Arnaud Da Cruz Paula, Thais Basili de Oliveira,Nadeem Abu-Rustum,Carol Aghajanian,Lora Ellenson, M. Herman Chui,Britta Weigelt

Gynecologic Oncology（2024）

引用0浏览0引用

Body Mass Index and Adiposity Influence Responses to Immune Checkpoint Inhibition in Endometrial Cancer

Nicolas Gomez-Banoy,Eduardo J. Ortiz,Caroline S. Jiang,Christian Dagher, Carlo Sevilla,Jeffrey Girshman,Andrew M. Pagano,Andrew J. Plodkowski,William A. Zammarrelli,Jennifer J. Mueller,Carol Aghajanian,Britta Weigelt,Vicky Makker,Paul Cohen,Juan C. Osorio

JOURNAL OF CLINICAL INVESTIGATIONno. 17 (2024)

引用0浏览0WOS引用

TROP2 As a Novel Target in Uterine Carcinosarcoma Organoid Models

Gynecologic Oncology (2024)

引用0浏览0引用

A Phase II Study of Fulvestrant and Abemaciclib in Hormone Receptor Positive Advanced or Recurrent Endometrial Cancer

Angela Green,Qin Zhou,Alexia Iasonos,William Zammarrelli,Britta Weigelt,Lora H. Ellenson, Rashmi Chhetri-Long,Pooja Shah, Vania Hom,Joseph P. Erinjeri,Iva Petkovska,Sarat Chandarlapaty,Seth M. Cohen,Rachel N. Grisham,Jason A. Konner,Maria M. Rubinstein,William P. Tew,Tiffany A. Troso-Sandoval,Carol Aghajanian,Vicky Makker

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2024)

引用0浏览0引用

Outcomes and long-term follow-up by treatment type for patients with advanced-stage ovarian cancer managed at a tertiary cancer center: A Memorial Sloan Kettering Cancer Center Team Ovary study

Sarah Ehmann,Kelly Shay, Qin Zhou,Alexia Iasonos,Yukio Sonoda,Ginger J. Gardner,Kara Long Roche,William A. Zammarrelli,Effi Yeoushoua,Roisin E. O'Cearbhaill,Oliver Zivanovic,Dennis S. Chi

Gynecologic oncology（2023）

引用4浏览0WOS引用

Adverse Events and Oncologic Outcomes with Combination Lenvatinib and Pembrolizumab for the Treatment of Recurrent Endometrial Cancer

William A. Zammarrelli,Weining Ma,Kevin Espino,Sushmita Gordhandas,Effi Yeoshoua,Sarah Ehmann, Qin Zhou,Alexia Iasonos,Nadeem R. Abu-Rustum,Carol Aghajanian,Angela K. Green,Maria M. Rubinstein,Vicky Makker

Gynecologic Oncology (2023): 27-35

引用0浏览0WOS引用

Current Evidence-Based Systemic Therapy for Advanced and Recurrent Endometrial Cancer

Sushmita Gordhandas,William A Zammarrelli,Eric V Rios-Doria,Angela K Green,Vicky Makker

Journal of the National Comprehensive Cancer Network JNCCN（2023）

引用5浏览0WOS引用

PROGNOSIS OF SURGICALLY STAGED FIGO IA UTERINE CARCINOSARCOMA WITHOUT MYOMETRIAL INVASION: A MULTICENTER INTERNATIONAL RETROSPECTIVE COHORT STUDY

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2023): A166-A166

引用0浏览0引用

Is there a Role for Using Immunotherapy in Endometrial Cancer

William A. Zammarrelli,Vicky Makker

Cambridge University Press eBookspp.226-228, (2023)

引用0浏览0引用

Real-world Outcomes and Adverse Events when Using Combination Lenvatinib and Pembrolizumab for the Treatment of Recurrent Uterine Cancer (1103)

William Zammarrelli,Weining Ma,Kevin Espino,Effi Yeoshoua,Sarah Ehmann,Qin Zhou,Alexia Iasonos,Nadeem Abu-Rustum,Carol Aghajanian,Angela Green,Maria Rubinstein,Vicky Makker

Gynecologic oncology (2023): S79-S80

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn